Build Metabolic Health Expertise Across Your Team
Help teams working in diabetes, obesity, and GLP-1 therapeutics build a stronger understanding of the science, drug development, and health care landscape. Harvard Medical School’s HMX and HealthXcelerate online courses offer learning options for colleagues in clinical development, medical affairs, commercial, R&D, and other functions.
Engaging by design
- Highly visual, interactive courses bring concepts to life through dynamic animations, videos, interactive activities, clinical applications, and assessments.
- Learning with lasting value: Learners earn a certificate of completion from Harvard Medical School and join a learning community committed to improving human health and well-being for all.
Learning for cross-functional teams
Give employees a shared learning experience—and help them build knowledge they can bring to their roles across the metabolic health landscape.
HMX: Explore the Medical Science
Strengthen understanding of the medical sciences behind metabolic health.
Courses to consider:
- GLP-1-Based Therapies: Mechanisms of Action, Development, and Clinical Impact: Examine incretin biology, how GLP-1 therapies are developed, and the clinical evidence shaping their use.
- Biochemistry Fundamentals: Build a foundation in metabolic pathways, energy, and how biochemical processes relate to diabetes and human disease.
- Pharmacology Essentials: Strengthen understanding of how drugs work, including pharmacokinetics, pharmacodynamics, and therapeutic applications.
HealthXcelerate: Understand the Health Care Context
Add health care industry context with HealthXcelerate
Courses to consider:
- GLP-1-Based Therapies: Cost, Coverage, and Access for Transformative Drugs: Explore how pricing, payer decisions, and access considerations shape the use of GLP-1 therapies.
- Inside Pharma and BioPharma Industries: Learn about the sectors’ structures, regulatory environments and market dynamics.
- Drug Development from Discovery Through Approval: Get a high-level view of the scientific and regulatory frameworks behind the drug development lifecycle.